Exclusive Insights on Spatial Genomics Market Latest Trends, Drivers, Strategies and Forecast

dbmr2145

posted on 2 weeks ago — updated on 1 second ago

23
views

Exclusive Insights on Spatial Genomics Market Latest Trends, Drivers, Strategies and Forecast

The higher A comprehensive understanding of the strategic study of partnerships, acquisitions, mergers, expansions, and investments is provided by the Spatial Genomics Market Research Report. Businesses can benefit from the market research analysis and data in this study when planning their production, product launches, costs, inventories, purchases, and marketing activities. This object-oriented market research report was created by combining the best talent solutions, industry insight, industry expertise, and the newest techniques and technology available. A useful resource for guidance and support for businesses and individuals interested in the industry is the Spatial Genomics Market study.

The extensive Spatial Genomics Market research provides an explanation of the market's definition, categories, uses, and interactions. The report's key factors will undoubtedly help the buyer study the global Spatial Genomics Market, taking into account the industry's past, present, and future states. These factors include competitive landscape analysis of leading manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis, and consumer needs by major regions, types, and applications. For a clear understanding of facts and figures, the numerical and statistical data has been indicated in a graphical manner.

Explore Further Details about This Research Spatial Genomics Market Report https://www.databridgemarketresearch.com/reports/global-spatial-genomics-market

Breast cancer is one of the most common cancers in the world. Breast cancer has the highest incidence of all cancers in women, according to a study published in January 2020. The study also stated that the annual incidence rate of breast cancer was over 1.6 million cases. This necessitates the use of early diagnostic procedures, which is where the role of particular genomics comes into play.

Data Bridge Market Research analyses that the spatial genomics market which is USD 204.01 million in 2022, is expected to reach USD 490.86 million by 2030, at a CAGR of 11.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Spatial genomics is the study of the entire set of genetic commands provided by DNA to detect and diagnose cancer tumour cells. Spatial genomics is used in disease control because it provides quantitative gene expression data. Spatial genomics also provides information on visualizing DNA and RNA mapping into tissue components.

Drivers

Rising applications of genomics

The increasing use of genomics and transcriptomics by academic institute researchers is one factor driving market growth. These techniques are widely used for the comprehensive evaluation of a wide range of diseases. For instance, a research institute like Children's Hospital for Philadelphia has experience in both locus discovery and GWAS in both academic and biotech settings. These have established a longitudinal and functional genomics centre to study the genetics of various diseases and the morphology of diseases resulting from genetic disorders such as cancer, diabetes, and Alzheimer's. Furthermore, genomic and transcriptomics technology has broader applications in the sector, such as the Human Cell Atlas. These are the certain factors which propel the market.

Increasing consumable adoption

Consumable's is significantly boosting the spatial genomics and transcriptomics market in the forecast period with a market share of 57.2% in 2021. The market's expansion is attributed to factors such as high product penetration, increasing consumable adoption, frequent use of kits and reagents for instruments in genomics and transcriptomics, and the wide availability of consumables. These instruments are used to prepare sample specimens for genomic mapping. Furthermore, advancements and new features in the consumables segment are increasing the adoption of biopharmaceuticals and research activities.

Recent Developments

In 2020, Cancer Transcriptome Atlas, a new product based on NanoString Technologies' GeoMx Digital Spatial Profiler (DSP) platform, is optimized for readout on Illumina's next-generation sequencing (NGS) technology, is available.
In 2020, S2 Genomics launched the Singulator 100 System, which automates the processing of solid tissue samples into suspensions of single cells or nuclei with high yields and from small samples for a variety of single-cell biology and genomic analyses.

Global Spatial Genomics Market Scope

The spatial genomics market is segmented on the basis of technology, end-user, product, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

Fluorescence in situ hybridization (FISH)
Microscopy-based Live DNA Imaging
Genome Perturbation Tools
Massively-Parallel Sequencing
Biochemical Techniques
Others

Product

Instruments
Consumables
Software

End-user

Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
Government Institutes and Academic Centers
Pharmaceutical and Biotechnology Companies
Contract Research Organizations

Application

Diagnostics and Disease Profiling
Drug Discovery
Others

Some of the major players operating in the spatial genomics market are:

Thermo Fisher Scientific Inc. (U.S.)
10X Genomics (U.S.)
NanoString Technologies Inc. (U.S.)
Illumina Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (U.S.)
Hoffmann-La Roche Ltd. (Switzerland)
S2 Genomics, Inc. (U.S.)
Seven Bridges Genomics (U.S.)
CARTANA AB (Sweden)
READCOOR, INC (U.S.)
Advanced Cell Diagnostics, Inc. (U.S.)
Dovetail Genomics (U.S.)
Novartis AG (Switzerland)
Pfizer Inc. (U.S.)
Merck & Co., Inc. (Germany)
Novo Nordisk A/S (Denmark)
Amgen Inc. (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
Gsk plc (U.K.)
Bayer AG (Germany)

Key questions answered in the Spatial Genomics Market are:

What is Spatial Genomics Market?
What was the Spatial Genomics Market size in 2022?
What are the different segments of the Spatial Genomics Market?
What growth strategies are the players considering to increase their presence in Spatial Genomics Market?
What are the upcoming industry applications and trends for the Spatial Genomics Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Spatial Genomics Market?
What major challenges could the Spatial Genomics Marketface in the future?
What segments are covered in the Spatial Genomics Market?
Who are the leading companies and what are their portfolios in Spatial Genomics Market?
What segments are covered in the Spatial Genomics Market?
Who are the key players in the Spatial Genomics Market?